首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Findings on MR sleep studies as biomarkers to predict outcome of genioglossus advancement in the treatment of obstructive sleep apnea in children and young adults.
【24h】

Findings on MR sleep studies as biomarkers to predict outcome of genioglossus advancement in the treatment of obstructive sleep apnea in children and young adults.

机译:MR睡眠研究的发现,作为生物标记物可预测舌肌进展在儿童和年轻人中阻塞性睡眠呼吸暂停的治疗结果。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: Genioglossus advancement, an operation to pull the tongue anteriorly, is a treatment of obstructive sleep apnea (OSA) secondary to glossoptosis. MRI predictors to identify which children will benefit from genioglossus advancement would be helpful for planning. We reviewed imaging findings on MR sleep studies as biomarkers to predict success or failure of genioglossus advancement in the treatment of OSA in children and young adults. MATERIALS AND METHODS: Twenty-eight patients who had undergone genioglossus advancement and preoperative MRI were identified. For each subject, genioglossus advancement, which was performed to treat OSA, was categorized as a success or failure on the basis of polysomnography and clinical criteria. Static and dynamic cine MR sequences were retrospectively evaluated for multiple parameters including measurements of the size of the tongue and of the bony confines of the supraglottic airway, the ratio of tongue size to bony confines size, static size and dynamic changes of the retroglossal airway, tonsil size, and soft palate thickness. Radiologists were blinded to the outcome of genioglossus advancement (i.e., success or failure category). Numeric biomarkers were compared in an analysis-of-covariance model adjusting for patient age. RESULTS: Genioglossus advancement was successful for the treatment of OSA in 17 patients and failed in 11 patients. The relative size of the tongue (tongue-bony confines ratio) was larger in patients with a successful surgical outcome than in those for whom the procedure failed (mean ratio, 0.51 vs 0.46; p = 0.023). Smaller adenoids were associated with a successful outcome (mean size of adenoids, 9.1 vs 12.4 mm; p = 0.049). No other biomarker-including absolute tongue size and airway size or dynamic airway motion-was significant. CONCLUSION: The relative (not absolute) tongue size and small size of the adenoid tonsils on MRI were predictors of success of genioglossus advancement for the treatment of glossoptosis causing OSA. These findings may be helpful in guiding surgical decision making in children with OSA.
机译:目的:舌Gen向前发展是一种向前拉舌头的手术,是继发于视光吞噬的阻塞性睡眠呼吸暂停(OSA)的一种治疗方法。 MRI预测因子可以确定哪些儿童将从舌肌发育中受益,这将有助于计划。我们回顾了在MR睡眠研究中的影像学发现,以此作为生物标志物来预测舌肌进展在儿童和年轻人中治疗OSA的成功或失败。材料与方法:确定了28例患有舌肌进展和术前MRI的患者。对于每位受试者,根据多导睡眠图和临床标准将舌肌的进展(用于治疗OSA)归类为成功或失败。对静态和动态电影MR序列进行了回顾性评估,以评估多个参数,包括舌头大小和声门上气道骨大小的测量,舌头大小与骨大小之比,静态大小和舌后气道的动态变化,扁桃体大小,软pa厚。放射科医生对舌肌进展的结果(即成功或失败类别)视而不见。在针对患者年龄进行调整的协方差分析模型中比较了数字生物标志物。结果:Gen舌肌进展成功治疗OSA 17例,失败11例。手术结果成功的患者的舌头相对大小(舌骨限制比)比手术失败的患者大(平均比,0.51 vs 0.46; p = 0.023)。较小的腺样体与成功的预后相关(腺样体的平均大小,9.1 vs 12.4 mm; p = 0.049)。没有其他生物标志物(包括绝对舌头大小和气道大小或动态气道运动)很重要。结论:MRI上相对(非绝对)的舌头大小和腺样体扁桃体小是预测舌s肌进展成功用于治疗引起OSA的舌苔症的指标。这些发现可能有助于指导OSA儿童的手术决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号